Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase 3 Study to Investigate the Efficacy and Safety of SYR-322 When Used in Combination With Insulin Preparation in Subjects With Type 2 Diabetes in Japan
alogliptin
SYR-322/CCT-901
NCT01521962
Diabetes Mellitus, Type 2
Phase 3
 
November 2015

Powered by ideaPoint, Inc.